Methenamine hippurate

CAS : 5714-73-8

Ref. 3D-FM30937

Informations sur le produit

• Nom: Methenamine hippurate
• Synonymes: 1,3,5,7-Tetraazatricyclo[3.3.1.1^3,7]decane, compd. with N-benzoylglycine (1:1), Glycine, N-benzoyl-, compd. with 1,3,5,7-tetraazatricyclo[3.3.1.1^3,7]decane (1:1), Haiprex, Hexamethylenetetramine hippurate, Hexamethylenetetramine hippuric acid complex, Hexamethylenetetramine, monohippurate, Hexamine hippurate, Hippramine, Hippuric acid, compd. with hexamethylenetetramine (1:1), Hiprex, Methenamine Hippurate, N-benzoylglycine - 1,3,5,7-tetraazatricyclo[3.3.1.1~3,7~]decane (1:1), R-657, Viapta, Glycine, N-benzoyl-, compd. with 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane (1:1), 1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane, compd. with N-benzoylglycine (1:1)

Description

Methenamine hippurate is a drug that has been used in the treatment of urinary tract infections. It is also used to prevent recurrence of these infections. Methenamine hippurate works by releasing formaldehyde, which inhibits the growth of bacteria by affecting their cell membrane. The release of formaldehyde is dependent on the concentration of methenamine and the pH, with a pH range from 7.0 to 8.5 being most effective for inhibiting bacterial growth. The release of formaldehyde can be inhibited by adding an acid to the urine sample or by adding hippurate to methenamine hippurate. Methenamine hippurate may cause drug interactions with other drugs that are eliminated through the kidneys, such as acetaminophen, sulfonamides, and indomethacin. This drug also has been shown to have therapeutic effects on choroidal neovascularization and geriatric patients with urinary tract infections.!--
END-->

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 319.36 g/mol
• Formule: C₆H₁₂N₄·C₉H₉NO₃
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder